SAN FRANCISCO–(BUSINESS WIRE)–Savonix, a global leader in digital tests for cognitive health, announced today that the company will present at the upcoming Alzheimer’s Association International Conference 2019 held from July 14-17, 2019, in Los Angeles, California. AAIC is the premier annual conference for presentation and discussion of the latest Alzheimer’s and dementia research.
Poster Presentation Details:
Title: Validity of a Novel Digitized Cognitive Screening App Used in Chinese Subjects with Mild Alzheimer’s Disease or Mild Cognitive Impairment
Date: Wednesday, July 17, 2019
Time: 9:30 AM – 4:15 PM
Location: Los Angeles Convention Center, South Hall GH
Presenting Author: Dr. Kevin Carroll, US Clinical Director, Savonix
Poster Number: 35143
“At Savonix, we envision a world without dementia, where digital cognitive assessment solutions are used to routinely monitor and track individual health to ultimately prevent Alzheimer’s Disease,” said Dr. Mylea Charvat, CEO and founder of Savonix. “Our lead product Savonix Mobile administers a wide range of neurocognitive domain tests, including executive function as well as impulse control and different types of memory. Memory loss and impairment are often the symptom most people associate with Alzheimer’s Disease and other dementias, but screening for memory alone is not sufficient to identify risk and misses the early signs of dementia. Given that we know lifestyle factors play a vital role in the development of dementias, it is important that early detection and other cognitive screening solutions are multi-domain instead of single domain tests, to identify individuals when there is often still time to intervene and slow disease progression through lifestyle changes and behavior modification.”
Savonix will also be co-hosting “Preparing Us for a Cure,” a breakfast panel discussion with UsAgainstAlzheimer’s and other global leaders in brain health on Wednesday, July 17, 2019, from 8:00 am – 10:00 am. The event will discuss how the healthcare system can ready itself to deploy new interventions, treatment, and tools to build a brain healthy population, free from Alzheimer’s. The event will be held at the South Park Center, North Suite, 1150 S Olive Street, in Los Angeles, CA. Interested parties can register here: email@example.com.
Meet the Savonix team at Exhibit Booth #220 at the AAIC 2019 conference.
About The Alzheimer’s Association International Conference® (AAIC®)
The Alzheimer’s Association International Conference (AAIC) is the world’s largest gathering of researchers from around the world focused on Alzheimer’s and other dementias. As a part of the Alzheimer’s Association’s research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.
Savonix delivers a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet, the Savonix Cognitive Assessment platform is an accurate, accessible and affordable tool for professional cognitive screens. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuropsychologists and digital health technology experts, the company has established itself as an authority on cognition globally. To learn more about Savonix, visit Savonix.com.